Terin Adali | Tissue Engineering | Excellence in Research Award

Prof. Dr. Terin Adali | Tissue Engineering | Excellence in Research Award

Faculty of Medicine at  Girne American University | Cyprus

Prof. Dr. Terin Adalı is a leading scholar in biomedical engineering whose scientific contributions span biomaterials, tissue engineering, drug delivery, biosensors, and polymer science, supported by a Scopus record of 392 citations, 25 documents, and an h-index of 12. Her research focuses on the synthesis, modification, and biocompatibility assessment of natural and synthetic polymers-including silk fibroin, chitosan, polyethylene glycol derivatives, and gellan gum-based systems-for regenerative medicine and therapeutic applications. She has extensively explored silk fibroin as a non-thrombogenic biomaterial, developing advanced hydrogels, injectable matrices, and composite scaffolds with applications in cartilage regeneration, ocular therapy, and sustained drug release. Her studies on PEG–DNA complexes, nanoparticle-encapsulated anticancer agents, and antibiotic-loaded biomaterials have contributed to improved targeted delivery and enhanced cellular outcomes. She has also developed polymer-based electrochemical biosensors for disease detection and micro/nanoparticles for biomedical imaging and cancer therapy. Her publications in high-impact journals demonstrate excellence in material characterization, spectroscopic analysis, cell viability assays, hemocompatibility studies, and the integration of AI-driven modeling techniques for medical diagnostics. She has contributed significantly to the understanding of scaffold–cell interactions, natural polymer reinforcement, and biodegradable material performance under physiological conditions. Her recent work includes advanced hydrogels for macular degeneration treatment and predictive models for osteoporosis using CT/MRI-based deep learning. Through her extensive scientific output, interdisciplinary collaborations, and role in shaping biomedical materials research, Prof. Dr. Terin Adalı has established a strong international presence and continues to advance innovative biomaterial technologies with impactful clinical potential.

Profiles : Scopus | Google Scholar

Featured Publications

Adali, T., Kalkan, R., & Karimizarandi, L. (2019). The chondrocyte cell proliferation of a chitosan/silk fibroin/egg shell membrane hydrogels. International Journal of Biological Macromolecules, 124, 541–547. (Cited by: 50)

Adalı, T., & Uncu, M. (2016). Silk fibroin as a non-thrombogenic biomaterial. International Journal of Biological Macromolecules, 90, 11–19. (Cited by: 50)

Yilmaz, E., Adali, T., Yilmaz, O., & Bengisu, M. (2007). Grafting of poly(triethylene glycol dimethacrylate) onto chitosan by ceric ion initiation. Reactive and Functional Polymers, 67(1), 10–18. (Cited by: 43)

Bahramzadeh, E., Yilmaz, E., & Adali, T. (2019). Chitosan-graft-poly(N-hydroxy ethyl acrylamide) copolymers: Synthesis, characterization and preliminary blood compatibility in vitro. International Journal of Biological Macromolecules, 123, 1257–1266. (Cited by: 40)

Adali, T., & Yilmaz, E. (2009). Synthesis, characterization and biocompatibility studies on chitosan-graft-poly(EGDMA). Carbohydrate Polymers, 77(1), 136–141. (Cited by: 40)

 

Serab Khan | Organic Chemistry | Best Researcher Award

Mr. Serab Khan | Organic Chemistry | Best Researcher Award

Research Fellow at H.E.J. Research Institute for Chemical and Biological Sciences, Pakistan

Dr. Serab Khan, Ph.D. (2024), is a dedicated researcher with an extensive background in organic and medicinal chemistry, focusing on the isolation, derivatization, and characterization of natural products, alongside the synthesis of heterocyclic compounds and a variety of peptides including linear, cyclic, and conjugate forms. His research has centered on developing new analogs of antimicrobial compounds and exploring phytochemicals from Salvadora persica L., making significant contributions to drug development and natural product chemistry. Dr. Khan’s academic journey has been rigorous and impactful, beginning with a Ph.D. at the International Center for Chemical and Biological Sciences (ICCBS), where his research explored novel phytochemicals and synthesized bioactive antimicrobial analogs. His M.Phil. research, also at ICCBS, delved into “Synthesis and Structural Studies of Biologically Important Peptides,” laying the groundwork for his future innovations in peptide synthesis and bioactivity studies. He holds an M.Sc. in Organic Chemistry from the Federal Urdu University of Arts, Science and Technology, a B.Sc. in Chemistry from Kohat University-affiliated college, an F.Sc. from Darra Adam Khel Degree College, and foundational SSC education from G.H.S under the Peshawar Board. In addition to his academic degrees, he also earned a CT from the Capital Institute of Education and a B.Ed. from Allama Iqbal Open University, reflecting his passion for education and pedagogy.

Education

Professionally, Dr. Khan is currently a Visiting Researcher at the University of Nizwa in Oman since October 2024, collaborating on advanced phytochemical analysis and spectroscopic techniques. Prior to this, he served as a Research Fellow at ICCBS in May 2024 and held a Junior Research Fellow position at the same center from April 2015 to May 2019, where he gained practical experience in molecular design and spectroscopic analysis. Earlier in his career, between 2011 and 2015, he was the Principal at Hira Model High School in FR Peshawar, demonstrating strong leadership and educational administration capabilities. His diverse career path reflects a blend of scientific inquiry and academic leadership, underlining his commitment to science and education.

Experience

Dr. Khan’s research interests span natural product chemistry, bioorganic synthesis, peptide chemistry, and antimicrobial compound development. His work on synthesizing novel analogs and bioactive molecules contributes to medical research targeting antimicrobial resistance, cancer, and enzyme inhibition. He has developed innovative methods, such as fluorescence spectroscopy coupled with chemometric models like Partial Least Square Regression (PLSR), for natural compound quantification, demonstrating his interdisciplinary skills bridging chemistry, biology, and analytical sciences.

Research Focus

His academic and scientific achievements have earned him several awards and recognitions. He actively participated in prestigious international symposiums such as the 7th MMDR in 2019, ISNPC-14 in 2018, ISNPF-2 in 2018, and MMDR-6 in 2017, where he presented posters and attended workshops. His scientific excellence was acknowledged with a laptop under the Prime Minister’s Scheme in 2018, and he earned a free GRE voucher and later cleared the GRE Chemistry test with an impressive score of 72.39% in 2016. He was also a recipient of the HEC Merit-Based Scholarship between 2015 and 2019, reinforcing his standing as a promising scholar in Pakistan’s research landscape.

Publications

Dr. Khan has authored several impactful publications in peer-reviewed journals. In 2022, he co-authored “Synthesis of non-ionic surfactants nano-vesicles for clarithromycin oral delivery,” exploring enhanced drug delivery systems. His 2021 publication in Medicinal Chemistry Research titled “Inhibition of jack bean urease by amphiphilic peptides” investigated enzyme inhibition mechanisms. In 2020, he contributed to Biomolecules with a study on “Furan-conjugated tripeptides as potent antitumor drugs”, reflecting his focus on cancer therapeutics. His 2019 paper in Journal of Molecular Liquids examined “Peptide-conjugated silver nanoparticles for selective detection of Hg²⁺ in human plasma and tap water,” merging nanotechnology and environmental monitoring. He also collaborated on a 2018 study in Journal of Asian Natural Products Research on “Leishmanicidal and antibacterial metabolites from Olea ferruginea.” Two of his most recent manuscripts—“Triterpenoid saponins from Tetrapleura tetraptera” and “Modulating Indanol Activity: Derivatization Strategies for Enhanced Enzyme Inhibition and Anticancer Potential”—have been submitted for publication. Collectively, his works have been cited 122 times with an h-index of 7 and an i10-index of 5, indicating his rising influence in the scientific community.

Conclusion

In conclusion, Dr. Serab Khan exemplifies a modern chemist with a passion for natural product research, bioorganic synthesis, and applied medicinal chemistry. His journey from academia to international research collaboration reflects a deep commitment to innovation and scientific contribution. With his expertise, interdisciplinary approach, and dedication to research excellence, Dr. Khan continues to push the boundaries of bioactive compound development and analytical methodology. His future promises impactful discoveries in natural therapeutics and molecular drug design, making him a strong contender for any award recognizing outstanding contributions in chemical and biological sciences.